Oncology Pharma inks license agreement for mrna intellectual property
Apr. 07, 2021 3:40 PM ETOncology Pharma Inc. (ONPH)By: Aakash Babu, SA News Editor
Oncology Pharma (OTCPK:ONPH +10.0%) has signed a license agreement with Regen BioPharma for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. The license agreement expands the company's portfolio of intellectual property that it plans to develop for niche biotechnology markets.